AQR Capital Management
MCRB icon

AQR Capital Management’s Seres Therapeutics MCRB Stock Holding History

AQR Capital Management’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,344
Closed -$129K – 2646
2024
Q1 		$129K Buy
8,344
+6,961
+503% +$150K ﹤0.01% 2314
2023
Q4 		$38.7K Buy
1,383
+631
+84% +$16.6K ﹤0.01% 2313
2023
Q3 		$35.8K Sell
752
-233
-24% -$17.8K ﹤0.01% 2298
2023
Q2 		$94.4K Buy
+985
New +$107K ﹤0.01% 2146
2022
Q4 		– Sell
-12,696
Closed -$1.63M – 2246
2022
Q3 		$1.63M Sell
12,696
-4,870
-28% -$499K ﹤0.01% 1295
2022
Q2 		$1.21M Buy
17,566
+4,246
+32% +$366K ﹤0.01% 1335
2022
Q1 		$1.9M Buy
13,320
+11,005
+475% +$1.69M ﹤0.01% 1213
2021
Q4 		$386K Sell
2,315
-2,352
-50% -$374K ﹤0.01% 1903
2021
Q3 		$650K Buy
4,667
+3,124
+202% +$611K ﹤0.01% 1758
2021
Q2 		$736K Buy
1,543
+517
+50% +$218K ﹤0.01% 1709
2021
Q1 		$423K Sell
1,026
-1,150
-53% -$530K ﹤0.01% 1900
2020
Q4 		$1.07M Sell
2,176
-862
-28% -$505K ﹤0.01% 1471
2020
Q3 		$1.72M Buy
+3,038
New +$1.01M ﹤0.01% 1178
2020
Q1 		– Sell
-7,157
Closed -$494K – 2109
2019
Q4 		$494K Sell
7,157
-4,585
-39% -$340K ﹤0.01% 1754
2019
Q3 		$942K Buy
+11,742
New +$776K ﹤0.01% 1539

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management's MCRB Position: Q2 2024 in Review

AQR Capital Management sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 8,344 shares — an estimated $129K sold.

AQR Capital Management first reported a position in MCRB in Q3 2019 and held it in 15 quarters. The position peaked at $1.9M in Q1 2022. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.

  • AQR Capital Management reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
  • AQR Capital Management sold 8,344 Seres Therapeutics shares in Q2 2024, an estimated $129K.
  • AQR Capital Management first reported a position in Seres Therapeutics in Q3 2019 and held it in 15 quarters.
  • AQR Capital Management's Seres Therapeutics position peaked at $1.9M in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.

Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.